Frederic L Sax

Title: The Innovations of Frederic L. Sax

Introduction

Frederic L. Sax is a notable inventor based in Villanova, PA (US). He has made significant contributions to the field of medicine, particularly in the area of platelet aggregation and angioplasty procedures. With a total of 2 patents, his work has had a meaningful impact on patient care and treatment options.

Latest Patents

Frederic L. Sax's latest patents include innovative methods for inhibiting platelet aggregation. One patent describes a method for inhibiting platelet aggregation in a mammal by administering a safe and therapeutically effective amount of a GPIIb/IIIa receptor antagonist or a pharmaceutically acceptable salt thereof, along with low molecular weight heparin. Another patent outlines a similar method using a specific compound, (2-S-(n-butylsulfonylamino)-3[4-(piperidin-4-yl)butyloxyphenyl]-propionic acid, combined with low molecular weight heparin. Additionally, he has developed a method for treating patients in need of percutaneous transluminal coronary angioplasty by administering nonionic contrast media and a fibrinogen receptor antagonist.

Career Highlights

Frederic L. Sax is associated with Merck & Co., Inc., where he has been able to apply his expertise in developing innovative medical treatments. His work has contributed to advancements in cardiovascular care, particularly in improving the safety and efficacy of angioplasty procedures.

Collaborations

Frederic has collaborated with esteemed colleagues such as Robert J. Gould and Jacquelynn J. Cook. These partnerships have fostered a collaborative environment that encourages innovation and the development of new medical solutions.

Conclusion

Frederic L. Sax's contributions to the field of medicine through his patents and collaborations highlight his commitment to improving patient outcomes. His innovative approaches to platelet aggregation and angioplasty procedures continue to influence the medical community.